Form D · Biotechnology
Jivana Biotechnology Inc
Oak Park, IL · CIK 0001659624
Offering snapshot reported Dec 20, 2017 · SEC filing
- Reported sold
- $65K Offering amount: $2M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Dec 4, 2017 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 20, 2017 | Initial | $65,000 | No comparison | 2 | SEC filing |
| Oct 25, 2016 | Amendment | $1,000,000 | No comparison | 0 | SEC filing |
| Jul 19, 2016 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Jul 15, 2016 | Amendment | $1,000,000 | No comparison | 16 | SEC filing |
| Jul 13, 2016 | Amendment | Yet to sell | No comparison | 0 | SEC filing |
| Nov 30, 2015 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Debt
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-301246
Source: Form D, filed Dec 20, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Sidney D. Hopps | Director, Executive |
| Bellur Prabhakar | Director, Executive |
| Patrick Sage | Director |
| Richard S. Schuler | Director |
| Kenneth J. Templin | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1010 Lake Street, Suite 200
Oak Park, IL, 60301
Oak Park, IL, 60301